TC Medical(SH:600763) Sou Hu Cai Jing·2026-01-26 12:30Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Tongce Medical (600763), including stock price movement and trading volume [1] - As of January 26, 2026, Tongce Medical's stock closed at 46.47 yuan, down 0.71%, with a turnover rate of 1.85% and a trading volume of 82,900 hands, resulting in a transaction amount of 385 million yuan [1] - The net capital outflow from major funds was 5.29 million yuan, accounting for 1.38% of the total transaction amount, while retail investors saw a net inflow of 4.94 million yuan, representing 1.28% of the total transaction amount [1] Group 2 - In the third quarter of 2025, Tongce Medical reported a main revenue of 842 million yuan, an increase of 2.34% year-on-year, and a net profit attributable to shareholders of 192 million yuan, up 2.31% year-on-year [2] - The company's total revenue for the first three quarters of 2025 reached 2.29 billion yuan, reflecting a year-on-year growth of 2.56%, with a net profit of 514 million yuan, which is a 3.16% increase year-on-year [2] - The company's debt ratio stands at 25.1%, with an investment income of 41.22 million yuan and financial expenses of 31.93 million yuan, while the gross profit margin is reported at 41.69% [2] Group 3 - Over the past 90 days, five institutions have provided ratings for Tongce Medical, with three buy ratings and two hold ratings, and the average target price set at 52.15 yuan [2]